[1] |
MA Yan, TIAN Gaopeng, SHI Xingwen, SUN Ting, XIE Jingjing, ZHEN Donghu.
Correlation between 25(OH)D and metabolically related fatty liver in T2DM population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1018-1026.
|
[2] |
HE Lihua, ZHU Xiuzhi, JIANG Yizhou.
Research progress on immunotherapy for triple-negative breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 842-853.
|
[3] |
MA Xiankang, YANG Lixia, CUI Yangyang, MI Denghai.
Angelica polysaccharides improve hepatic endoplasmic reticulum stress by inhibiting the expression of GRP78, p-PERK and p-Eif2α in diabetic KK-Ay mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 926-936.
|
[4] |
LI Kun, LI Lulu, LI Nannan, HU Weihong, ZHOU Jianchao.
Effects of glycaemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 767-774.
|
[5] |
LI Shuang, HAN Shuzhen, DAI Yuting, XIU Minghui, DU Xianqin, HE Jianzheng, LIN Xingyao.
Progress in the prevention and treatment of traditional Chinese medicine based on the mechanism of intestinal injury of various chemotherapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 583-593.
|
[6] |
HOU Ruiying, GUO Lige, JIAO Weijie, DU Lei, WU Guiyue, ZHAO Xu.
Effects of Xiaokeshu recipe on levels of serum inflammatory factors in type2 diabetic rats and its mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 377-382.
|
[7] |
ZHANG Xuejiao, LIU Jieting, LI Luxin, CHEN Peijian, DING Minglu, SUN Mengwei, CHU Yanhui, ZHANG Zhen .
Effects and mechanism of dapagliflozin on myocardial injury in type 1 diabetes mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 257-265.
|
[8] |
CAO Fang, QIN Kairong, ZHENG Guoshuang, ZHAO Dewei.
Exploring the intervention mechanism of Ginkgo biloba for steroid-induced necrosis of the femoral head based on network pharmacology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 266-275.
|
[9] |
ZHANG Li, LIN Xingyao, SHANG Yun, WANG Qiang.
Progress on the pathological mechanism and treatment of frostbite
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 347-354.
|
[10] |
LI Xinyu, HUANG Xin.
State of clinical application of meloxicam
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 189-197.
|
[11] |
ZHAO Shifeng, SONG Xiangming, YAO Jianping.
Tirzepatide: A new glucagon-like peptide-1 receptor/glucose-dependent insulinotropic peptide receptor dual agonist
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 220-227.
|
[12] |
CHEN Yulin, JIANG Hugang, WANG Xinqiang, LIU Kai, LI Yingdong, AN Tao, ZHAO Xinke.
Effects and mechanism of Ginseng Yixin granules (QSYXG) for heart failure with preserved ejection fraction based on the network pharmacology and molecular docking strategy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1081-1092.
|
[13] |
LIU Dan, LIU Ming, JIN Liangyou, PAN Juan, XIN Haoru, LIU Mengyuan, LI Xin, ZHENG Kun, FENG Xiaoling.
Research progress on the antitumor activity of costunolide
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1168-1176.
|
[14] |
DU Xiaoyu, LI Yumeng, WU Huizhen, QIU Bo.
Pharmacological and clinical evaluation of Dorzagliatin in the treatment of type 2 diabetes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1177-1183.
|
[15] |
CAI Jing, PAN Binjing, LIU Jingfang.
Research progress on the relationship between hypoglycemic drugs and sarcopenia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 101-108.
|